The Redefine Study (COMP202) is testing COMP360 to see if it may reduce post-traumatic stress disorder (PTSD) symptoms when administered alongside monitoring a…

PTSD - Post Traumatic Stress DisorderPTSDPTSD Symptoms+1 more

~Estimated

~$10 – $7,500

COMPASS PathwaysNCT07570654

Phase 1

Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study

The primary objective of this study is to investigate the safety, feasibility, and tolerability of psilocybin treatment in individuals with functional impairme…

TransdiagnosticDepression - Major Depressive DisorderAnxiety+5 more

~Estimated

~$10 – $6,250

Yale UniversityNCT06442423